ABSTRACT
Cellular behaviors are modulated by a variety of stimuli in the environment, which can be generally categorized
as chemical, physical, and biological factors. Previous work suggests that physical forces, both at the mesoscale
of cell-cell interactions and the microscale of ligand-receptor binding events, play a critical role in regulating cell
physiology. For example, stem-cell differentiation is regulated by neighboring cells and the stiffness of the
extracellular matrix, while T cells are better activated by target cells with a mechanically strong cortex. The T-
cell receptor also bears forces exerted from the pMHC, which affects receptor activation in a non-monotonic
manner. While a plethora of evidence suggests the critical role of mechanical force in regulating cell fate and
activation states, force itself has rarely been considered or exploited as a target for cell engineering and
therapeutics development. Major hurdles include the lack of effective sensors that can digitally sense mechanical
forces, and the lack of genetically encoded intracellular devices that can convert mechanical forces into a
signaling cascade that modulates cell states. In this proposal, we will combine state-of-the-art technologies in
protein design, RNA synthetic biology, and cell engineering to develop “mechaswitches”: universal, modular and
programmable signal transduction systems that are able to trigger specific cellular actions in response to
mechanical signals. Each mechaswitch is composed of a protein-based force sensor inserted within a force-
bearing protein of interest and a transducer mRNA that implements a desired cellular action. When the protein
of interest is subjected to a defined range of forces, the mechaswitch force sensor responds by changing its
conformation. This conformational change is in turn detected by a sensing element within the transducer mRNA
that either switches on or off the expression of specific proteins that modulate cell behavior. We will develop
sensors covering a wide range of molecular forces and RNA switches that control protein expression with high
fidelity. In proof-of-principle experiments, we will apply mechaswitches to program cell differentiation in defined
extracellular environments and to modulate T cell proliferation and activation in response to specific antigens.
Because of the modularity of mechaswitches, which enables their sensing and output components to be rapidly
swapped and recombined, we envision a host of other uses for mechaswitches that could transform the study
and application of mechanical forces in cell biology. The successful realization of this project is expected to not
only advance basic research in mechanobiology, but also lay the foundation for the first therapeutic strategies
informed by the mechanical signals and target mechano-properties of diseased cells and proteins.
Public Health Relevance Statement
NARRATIVE
The proposed research aims to engineer cells with force-responsive molecular devices that can modulate cell
differentiation and T cell-based immune response. The results could lead to new strategies that improve cancer
treatment and regeneration. Thus, this work is relevant to the NIH’s mission to reduce illness and disability.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
09-September-2024
Project End Date
31-August-2029
Budget Start Date
09-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$1,508,357
Direct Costs
$1,095,000
Indirect Costs
$413,357
Year
Funding IC
FY Total Cost by IC
2024
NIH Office of the Director
$1,508,357
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01EB037112-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01EB037112-01
Patents
No Patents information available for 1R01EB037112-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01EB037112-01
Clinical Studies
No Clinical Studies information available for 1R01EB037112-01
News and More
Related News Releases
No news release information available for 1R01EB037112-01
History
No Historical information available for 1R01EB037112-01
Similar Projects
No Similar Projects information available for 1R01EB037112-01